EVIDENCE-BASED MEDICINE
Developing and Testing Adaptive Treatment Strategies Using Substance-Induced Psychosis as an Example
By Ree Dawson, Alan I. Green, Robert E. Drake, Thomas H. McGlashan, Bella Schanzer, Philip W. Lavori
-
Development of Antagonists of the Platelet-Derived Growth Factor Receptor Family
By Neill A. Giese, PhD, Nathalie A. Lokker, PhD, Jin-Chen Yu, PhD, Kenji Matsuno, PhD, Michio Ichimura, PhD, Shoji Oda, PhD, Robert Scarborough, PhD, and Anjali Pandey, PhD
-
Development of STI571 and Its Use in Chronic Myelogenous Leukemia and Other Malignancies
By Michael J. Mauro, MD, Michael E. O’Dwyer, MD, and Brian J. Druker, MD
-
Diagnosis and Staging of Gynecological Malignancies
By Brigitte E. Miller, MD
-
Diagnosis and Treatment of Depression in the Cancer Patient
Tracy L. Skaer, PharmD, Linda M. Robison, MSPH, David A. Sclar, PhD
-
Diferencias de género en el trastorno depresivo mayor y el trastorno bipolar
Dra. Ellen Leibenluft
-
Divalproex and Epilepsy
By L. James Willmore, MD
-
Divalproex in the Treatment of Bipolar Disorder
By Paul E. Keck, Jr, MD, and Susan L. McElroy, MD
-
Divalproex in the Treatment of Migraine
By Frederick G. Freitag, DO
-
Does Isotretinoin Cause Depression and Suicide?
By J. Douglas Bremner, MD
-
¡Bienvenidos a
Psiquiatría y Salud Integral!
Dr. Juan E. Mezzich y Dr. Miguel R. Jorge
-
Drug Development for Anxiety Disorders: New Roles for Atypical Antipsychotics
By William H. Carson, MD, Hisashi Kitagawa, PhD, and Charles B. Nemeroff, MD, PhD
